If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,395.00    95.00 (1.51%)
Bid:
6,380.00
Ask:
6,390.00
Spread: 10.00 (0.157%)
Market Cap: £4.72b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

AGM Statement - Trading Update

15 May 2018 07:00

RNS Number : 0291O
Spirax-Sarco Engineering PLC
15 May 2018
 

 

 

News Release

 

Tuesday 15th May 2018

AGM Statement - TRADING UPDATE

Overall expectations unchanged, acquisitions continue to perform in line with plan

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam, electrical thermal energy solutions and peristaltic pumping and associated fluid path technologies, issues the following trading update in respect of the period ended 30th April 2018.

 

Economic environment

The global macro-economic environment for the Group remains positive with global Industrial Production (IP) growth for 2018 forecast to be very similar to that achieved in 2017.

 

Trading

In line with the macro-economic environment and as anticipated at the time of our preliminary announcement in March, organic* sales growth for the Group in the first four months of the year has been very similar to the first four months of 2017 for both the Steam Specialties and Watson-Marlow businesses. Within the Steam Specialties business we have seen improved growth in the Americas, while growth has been lower in Asia Pacific and EMEA, albeit both segments had a very strong start to the year in 2017. Watson-Marlow continues to see growth in EMEA, Asia Pacific and the Americas.

 

The integration of the two acquisitions made in 2017, Gestra which was acquired in May and Chromalox which joined the Group in July, is progressing to schedule and the businesses continue to perform in line with their respective acquisition plans.

 

As expected, the currency tailwind that we experienced in the last two years has become a headwind in the current year. Since the announcement of our preliminary results in March, sterling has strengthened slightly against the basket of currencies we trade in. If April's foreign exchange rates were to continue for the rest of the year we would expect to see a reduction in sales and profits due to currency movements of 3% and 5% respectively. Movements in exchange rates are often volatile and unpredictable, therefore the actual impact could be significantly different.

 

On an organic, constant currency basis, Group operating profit is ahead of the comparable four-month period in 2017 and we continue to prioritise investments for growth over further margin expansion.

 

 

Financial position

Our business remains highly cash generative and we maintain a strong balance sheet. At 30th April 2018 net debt was £345 million. There has been no material change in the financial position of the Group during the period.

 

 

Outlook

We have good diversification across market sectors and geographic regions, and remain focused on the rigorous implementation of our strategies for growth. While, as normal, our short order book continues to provide only limited visibility, the Group's fundamental strengths stand us in good stead to continue to deliver growth that outperforms our markets.

 

Organic sales growth in the first four months has been very much as anticipated and is consistent with that experienced in the same period in the prior year. With forecasts for Industrial Production growth rates for 2018 also similar to those seen in 2017 our overall expectations of organic growth and trading margins for the full-year are unchanged to those set out in our preliminary announcement in March. Provided there is no material deterioration in trading conditions the Board has confidence that the Group will make further progress in 2018.

 

Spirax-Sarco Engineering plc expects to publish its 2018 half-year results on Wednesday 8th August 2018.

 

Enquiries:

Nicholas Anderson, Chief Executive

Kevin Boyd, Group Finance Director

Tel: 01242 535234

 

 

* References to organic changes are excluding acquisitions and disposals, and are expressed at constant currency.

References to profit are to adjusted profit that excludes the amortisation and impairment of acquisition-related intangible assets and acquisition and disposal costs, together with the tax effects of these items.

 

About SpiraxSarco Engineering plc

SpiraxSarco Engineering plc comprises two worldleading businesses, Spirax Sarco for steam and electrical thermal energy solutions and WatsonMarlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies.  Spirax Sarco provides a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The business helps its end users to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. WatsonMarlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies.  The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs over 7,250 people, of whom approximately 1,600 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

 

Further information can be found at www.spiraxsarcoengineering.com

 

RNS filter: Inside information prior to release

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMGGUCUAUPRGQC
Date   Source Headline
6th Feb 20187:30 amRNSChange of Director Details
20th Dec 20179:07 amRNSChange of Director Details
27th Nov 20174:00 pmRNSDirector/PDMR Shareholding
21st Nov 20173:08 pmRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSTrading Statement
14th Nov 201710:39 amRNSDirector/PDMR Shareholding
16th Oct 20175:35 pmRNSDirector/PDMR Shareholding
29th Sep 20173:36 pmRNSHolding(s) in Company
9th Aug 20177:00 amRNSHalf-year Report
4th Jul 20177:00 amRNSCompletion of Acquisition
23rd Jun 20179:11 amRNSTotal Voting Rights
20th Jun 20173:59 pmRNSHolding(s) in Company
12th Jun 20172:20 pmRNSDirector/PDMR Shareholding
5th Jun 20179:08 amRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSAcquisition of Chromalox for US$415 million
9th May 20174:30 pmRNSResult of AGM
9th May 20177:00 amRNSTrading Statement
4th May 20174:30 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSCompletion of Acquisition
26th Apr 20178:42 amRNSHolding(s) in Company
25th Apr 20179:10 amRNSHolding(s) in Company
19th Apr 20173:55 pmRNSHolding(s) in Company
18th Apr 20173:58 pmRNSHolding(s) in Company
3rd Apr 20177:30 amRNSAcquisition
24th Mar 20174:44 pmRNSTotal Voting Rights
23rd Mar 20171:45 pmRNSDirector/PDMR Shareholding
17th Mar 20174:04 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSFinal Results
30th Nov 20167:00 amRNSAcquisition
22nd Nov 20167:00 amRNSTrading Statement
17th Nov 20164:23 pmRNSDirector/PDMR Shareholding
14th Nov 20168:30 amRNSDr Krishnamurthy Rajagopal
10th Nov 201611:40 amRNSListing Application
8th Nov 201611:57 amRNSChange of Director Details
4th Nov 20164:27 pmRNSTotal Voting Rights
28th Oct 20167:00 amRNSBoard Succession Changes
17th Oct 20162:49 pmRNSAdditional Listing
14th Oct 20165:03 pmRNSDirector/PDMR Shareholding
14th Oct 20163:20 pmRNSTotal Voting Rights
14th Oct 20163:17 pmRNSBlock listing Interim Review
6th Oct 201611:48 amRNSNotification of Release Date - Trading Statement
8th Sep 201612:44 pmRNSTotal Voting Rights
18th Aug 20168:30 amRNSBoard Appointment
12th Aug 20163:51 pmRNSDirector/PDMR Shareholding
9th Aug 20167:05 amRNSSpirax Sarco acquires assets of Hiter for £3.9 m
9th Aug 20167:00 amRNS2016 Half Year Results
5th Aug 20162:56 pmRNSTotal Voting Rights
1st Jul 201611:43 amRNSTotal Voting Rights
29th Jun 20169:29 amRNSNotice of Results
21st Jun 20165:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.